Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CD90 expression on human HEL cells. HEL cells (Human erythroleukemia cell line; ATCC TIB-180) were stained with either BD Horizon™ BUV395 Mouse Anti-Human CD90 antibody (Cat. No. 563804; solid line histogram) or BD Horizon™ BUV395 Mouse IgG1, κ Isotype Control (Cat. No. 563547; dashed line histogram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometry System.
Flow cytometric analysis of CD90 expression on human mesenchymal stem cells. Human mesenchymal stem cells (Lonza) at passage 7 were harvested using BD™ Accutase™ Cell Detachment Solution (Cat. No. 561527) and stained with either BD Horizon™ BUV395 Mouse anti-Human CD90 antibody (Cat. No. 563804; solid line histogram) or BD Horizon™ BUV395 Mouse IgG1, κ Isotype Control (Cat. No. 563547, dashed line histogram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometry was performed using aBD LSRFortessa™ Cell Analyzer System.
Flow cytometric analysis of CD90 expression on human HEL cells. HEL cells (Human erythroleukemia cell line; ATCC TIB-180) were stained with either BD Horizon™ BUV395 Mouse Anti-Human CD90 antibody (Cat. No. 563804; solid line histogram) or BD Horizon™ BUV395 Mouse IgG1, κ Isotype Control (Cat. No. 563547; dashed line histogram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometry System.
Flow cytometric analysis of CD90 expression on human mesenchymal stem cells. Human mesenchymal stem cells (Lonza) at passage 7 were harvested using BD™ Accutase™ Cell Detachment Solution (Cat. No. 561527) and stained with either BD Horizon™ BUV395 Mouse anti-Human CD90 antibody (Cat. No. 563804; solid line histogram) or BD Horizon™ BUV395 Mouse IgG1, κ Isotype Control (Cat. No. 563547, dashed line histogram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometry was performed using aBD LSRFortessa™ Cell Analyzer System.
Flow cytometric analysis of CD90 expression on human HEL cells. HEL cells (Human erythroleukemia cell line; ATCC TIB-180) were stained with either BD Horizon™ BUV395 Mouse Anti-Human CD90 antibody (Cat. No. 563804; solid line histogram) or BD Horizon™ BUV395 Mouse IgG1, κ Isotype Control (Cat. No. 563547; dashed line histogram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometry System.
Flow cytometric analysis of CD90 expression on human mesenchymal stem cells. Human mesenchymal stem cells (Lonza) at passage 7 were harvested using BD™ Accutase™ Cell Detachment Solution (Cat. No. 561527) and stained with either BD Horizon™ BUV395 Mouse anti-Human CD90 antibody (Cat. No. 563804; solid line histogram) or BD Horizon™ BUV395 Mouse IgG1, κ Isotype Control (Cat. No. 563547, dashed line histogram). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometry was performed using aBD LSRFortessa™ Cell Analyzer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The 5E10 monoclonal antibody specifically binds to human CD90 which is also known as Thy-1. CD90 is a 25-35 kDa glycophosphatidylinositol-anchored membrane glycoprotein of the Ig superfamily that is expressed on 1-4% of human fetal liver cells, cord blood cells, and bone marrow cells. The anti-CD90 antibody binds to a subset of immature CD34+ cells and a distinct subset of mature CD34- cells that are CD3+CD4+. The CD90+CD34+ population is highly enriched for cells capable of long-term culture. The anti-CD90 antibody is useful for enriching high proliferative potential colony-forming cells (HIPP-CFC) that are primative progenitor cells.
The antibody was conjugated to BD Horizon™ BUV395 which has been exclusively developed by BD Biosciences as an optimal dye for use on a 355 nm laser equipped instrument. With an Ex Max at 348 nm and an Em Max at 395 nm, this dye has virtually no spillover into any other detector. BD Horizon™ BUV395 can be excited with a 355 nm laser and detected with a 379/28 filter.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.